This collaboration is more than just an evaluation, it’s a pathway for Lumito to expand the company market presence and visibility outside Sweden. The success of this project could serve as a launchpad for wider adoption of Lumito's solution and position Lumito as an important player in tissue analysis, as well as paving the road for further commercialisation.

The project will be based on Lumito’s “scan-as-a-service” concept, where Concept Life Sciences will utilise Scizys Erbium kit to develop automated staining protocols before sending the samples to Lumito for high resolution scanning. The images and data from the scanning are then transferred back to Concept Life Sciences for analysis and evaluation.

"We are really excited about this collaboration with the skilled and experienced team from Concept Life Sciences. By working together, we aim to advance and enhance tissue analysis to meet the needs of Concept Life Science and their customers, adding value for both companies” says Sanna Wallenborg, CEO at Lumito.

"Lumito is generating some really exciting data, showcasing both the sensitivity and range of detection of their assay. This could be of real benefit to the spatial biology sector where accurate and measurable detection of protein can be difficult. We are really excited to be part of the development of such a technology" says Chris Mills, Senior Scientist, Concept Life Sciences.

“Our collaborative approach drives breakthroughs in spatial biology and biomarker discovery, leveraging high-quality data to advance target validation, tissue analysis, and precision medicine. At Concept Life Sciences, we partner with innovators like Lumito, using cutting-edge imaging and spatial profiling to unlock deeper biological insights. By integrating advanced spatial techniques, we accelerate biomarker discovery and therapeutic development, bringing precision therapies to patients faster” says Hayley Gooding, Biology Services Director, Concept Life Sciences.